Cargando…
The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295399/ https://www.ncbi.nlm.nih.gov/pubmed/37371660 http://dx.doi.org/10.3390/biomedicines11061565 |
_version_ | 1785063411322716160 |
---|---|
author | Pyromali, Ioanna Richard, Laurence Derouault, Paco Vallat, Jean-Michel Ghorab, Karima Magdelaine, Corinne Sturtz, Franck Favreau, Frédéric Lia, Anne-Sophie |
author_facet | Pyromali, Ioanna Richard, Laurence Derouault, Paco Vallat, Jean-Michel Ghorab, Karima Magdelaine, Corinne Sturtz, Franck Favreau, Frédéric Lia, Anne-Sophie |
author_sort | Pyromali, Ioanna |
collection | PubMed |
description | Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy symptoms using the CovCopCan bioinformatic tool, we discovered the presence of a deletion of around 3kb in ATL3 from Chr11:63,401,422 to Chr11:63,398,182. This deletion affects ATL3 exons 11 and 12 and could lead to the mutation c.(1036-861_1539+329del), p.(Ala346_Gln513del). In addition, an analysis of the breakpoints’ sequences revealed the presence of Alu transposable elements at the position of the breakpoints, which pointed to a possible erroneous recombination event following a non-allelic-homologous-recombination mechanism in this area. Moreover, electronic microscopy analysis of the patient’s nerve biopsy revealed a severe rarefaction of the myelinated fibers, a demyelinating–remyelinating process, and an abnormal aspect of the endoplasmic reticulum. These findings suggest that this structural variation could potentially be responsible for the HSN symptoms of the patient. Research of structural variations in ATL3 in numerous other patients presenting similar symptoms should be broadly investigated in order to improve patients’ diagnoses. |
format | Online Article Text |
id | pubmed-10295399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102953992023-06-28 The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy Pyromali, Ioanna Richard, Laurence Derouault, Paco Vallat, Jean-Michel Ghorab, Karima Magdelaine, Corinne Sturtz, Franck Favreau, Frédéric Lia, Anne-Sophie Biomedicines Article Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy symptoms using the CovCopCan bioinformatic tool, we discovered the presence of a deletion of around 3kb in ATL3 from Chr11:63,401,422 to Chr11:63,398,182. This deletion affects ATL3 exons 11 and 12 and could lead to the mutation c.(1036-861_1539+329del), p.(Ala346_Gln513del). In addition, an analysis of the breakpoints’ sequences revealed the presence of Alu transposable elements at the position of the breakpoints, which pointed to a possible erroneous recombination event following a non-allelic-homologous-recombination mechanism in this area. Moreover, electronic microscopy analysis of the patient’s nerve biopsy revealed a severe rarefaction of the myelinated fibers, a demyelinating–remyelinating process, and an abnormal aspect of the endoplasmic reticulum. These findings suggest that this structural variation could potentially be responsible for the HSN symptoms of the patient. Research of structural variations in ATL3 in numerous other patients presenting similar symptoms should be broadly investigated in order to improve patients’ diagnoses. MDPI 2023-05-28 /pmc/articles/PMC10295399/ /pubmed/37371660 http://dx.doi.org/10.3390/biomedicines11061565 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pyromali, Ioanna Richard, Laurence Derouault, Paco Vallat, Jean-Michel Ghorab, Karima Magdelaine, Corinne Sturtz, Franck Favreau, Frédéric Lia, Anne-Sophie The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy |
title | The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy |
title_full | The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy |
title_fullStr | The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy |
title_full_unstemmed | The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy |
title_short | The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy |
title_sort | first large deletion of atl3 identified in a patient presenting with a sensory polyneuropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295399/ https://www.ncbi.nlm.nih.gov/pubmed/37371660 http://dx.doi.org/10.3390/biomedicines11061565 |
work_keys_str_mv | AT pyromaliioanna thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT richardlaurence thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT derouaultpaco thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT vallatjeanmichel thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT ghorabkarima thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT magdelainecorinne thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT sturtzfranck thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT favreaufrederic thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT liaannesophie thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT pyromaliioanna firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT richardlaurence firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT derouaultpaco firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT vallatjeanmichel firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT ghorabkarima firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT magdelainecorinne firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT sturtzfranck firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT favreaufrederic firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy AT liaannesophie firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy |